Archives of Obesity and Metabolism (비만대사연구학술지)

The Study of Obesity and Metabolic Syndrome, KAFM (대한가정의학회 비만대사증후군연구회)
권호 표지
DOI QR코드

DOI QR Code

Factors Associated with Weight Gain and Its Prevention Strategies

체중 증가의 관련 요인과 예방책

  • Seung Hee Kim (Department of Family Medicine, Wonkwang University Sanbon Hospital, Wonkwang University School of Medicine)
  • 김승희 (원광대학교 의과대학 원광대학교 산본병원 가정의학과)
  • Received : 2023.09.03
  • Accepted : 2023.11.09
  • Published : 2023.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Weight gain is defined as the increase in body weight, increasing the prevalence of obesity, and results in metabolic diseases. Weight gain was reportedly caused by the interaction between the obesogenic environmental factors and individual metabolic factors. Sociodemographic and environmental factors (demographic factors, lifestyle/behavioral factors, food/nutritional factors, socioeconomic factors), drug-related secondary causes (some of the corticosteroids, antihyperglycemics, antihypertensives, antidepressants, etc.), and metabolic factors (aging and hormonal changes, menopause and decreased sex hormones, decreased adipocyte degradation, decreased fibroblast growth factor 21, central sympathetic nervous system hyperactivity, decreased sympathetic-adrenomedullary system activity) are significant factors related to weight gain. It is crucial to prevent weight gain and maintain an ideal weight, but studies on the risk factors of weight gain are insufficient. Therefore, this study evaluated the factors associated with weight gain to find strategies for preventing unnecessary weight gain.

Keywords

References

  1. World Health Organization (WHO). Obesity [Internet]. WHO. 2023 [cited 2023 Nov 4]; Available from: https://www.who.int/health-topics/obesity#tab=tab_1
  2. Institute for Health Metrics and Evaluation (IHME). Global burden of disease study 2015 (GBD 2015) obesity and overweight prevalence 1980-2015. Seattle, WA: IHME; 2017.
  3. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008;32:1431-7. https://doi.org/10.1038/ijo.2008.102
  4. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9. https://doi.org/10.1001/jama.282.16.1523
  5. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and metaanalysis. JAMA 2013;309:71-82. https://doi.org/10.1001/jama.2012.113905
  6. Hebden L, Chey T, Allman-Farinelli M. Lifestyle intervention for preventing weight gain in young adults: a systematic review and meta-analysis of RCTs. Obes Rev 2012;13:692-710. https://doi.org/10.1111/j.1467-789X.2012.00990.x
  7. Medical Subject Headings (MeSH). Weight gain [Internet]. MeSH. 2023 [cited 2023 Nov 4]; Available from: https://meshb.nlm.nih.gov/record/ui?ui=D015430
  8. Katsoulis M, Lai AG, Diaz-Ordaz K, et al. Identifying adults at high-risk for change in weight and BMI in England: a longitudinal, large-scale, population-based cohort study using electronic health records. Lancet Diabetes Endocrinol 2021;9:681-94. https://doi.org/10.1016/S2213-8587(21)00207-2
  9. Zheng Y, Manson JE, Yuan C, et al. Associations of weight gain from early to middle adulthood with major health outcomes later in life. JAMA 2017;318:255-69. https://doi.org/10.1001/jama.2017.7092
  10. Huh Y, Kim SH, Nam GE, Park HS. Weight gain, comorbidities, and its associated factors among Korean adults. J Korean Med Sci 2023;38:e90.
  11. Ravussin E, Gautier J. Metabolic predictors of weight gain. Int J Obes 1999;23(Suppl 1):S37-41. https://doi.org/10.1038/sj.ijo.0800793
  12. Hollstein T, Piaggi P. Metabolic factors determining the susceptibility to weight gain: current evidence. Curr Obes Rep 2020;9:121-35. https://doi.org/10.1007/s13679-020-00371-4
  13. Zizza C, Siega-Riz AM, Popkin BM. Significant increase in young adults' snacking between 1977-1978 and 1994-1996 represents a cause for concern! Prev Med 2001;32:303-10. https://doi.org/10.1006/pmed.2000.0817
  14. Yanovski SZ, Sebring NG. Recorded food intake of obese women with binge eating disorder before and after weight loss. Int J Eat Disord 1994;15:135-50. https://doi.org/10.1002/1098-108X(199403)15:2<135::AID-EAT2260150205>3.0.CO;2-I
  15. Todd JE, Mancino L, Lin BH. The impact of food away from home on adult diet quality. Washington, D.C.: U.S. Department of Agriculture, Economic Research Service; 2010.
  16. Binkley JK, Eales J, Jekanowski M. The relation between dietary change and rising US obesity. Int J Obes Relat Metab Disord 2000;24:1032-9. https://doi.org/10.1038/sj.ijo.0801356
  17. Must A, Tybor DJ. Physical activity and sedentary behavior: a review of longitudinal studies of weight and adiposity in youth. Int J Obes (Lond) 2005;29 Suppl 2:S84-96. https://doi.org/10.1038/sj.ijo.0803064
  18. Anderson DA, Shapiro JR, Lundgren JD. The freshman year of college as a critical period for weight gain: an initial evaluation. Eat Behav 2003;4:363-7. https://doi.org/10.1016/S1471-0153(03)00030-8
  19. Pereira MA, Kartashov AI, Ebbeling CB, et al. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet 2005;365:36-42. Erratum in: Lancet 2005;365:1030.
  20. Hankinson AL, Daviglus ML, Bouchard C, et al. Maintaining a high physical activity level over 20 years and weight gain. JAMA 2010;304:2603-10. Erratum in: JAMA 2011;305:150.
  21. Tian J, Venn A, Otahal P, Gall S. The association between quitting smoking and weight gain: a systematic review and meta-analysis of prospective cohort studies. Obes Rev 2015;16:883-901. Erratum in: Obes Rev 2016;17:1014.
  22. Chiolero A, Jacot-Sadowski I, Faeh D, Paccaud F, Cornuz J. Association of cigarettes smoked daily with obesity in a general adult population. Obesity (Silver Spring) 2007;15:1311-8. https://doi.org/10.1038/oby.2007.153
  23. Timlin MT, Pereira MA. Breakfast frequency and quality in the etiology of adult obesity and chronic diseases. Nutr Rev 2007;65(6 Pt 1):268-81. https://doi.org/10.1301/nr.2007.jun.268-281
  24. Levitsky DA, Pacanowski CR. Effect of skipping breakfast on subsequent energy intake. Physiol Behav 2013;119:9-16. https://doi.org/10.1016/j.physbeh.2013.05.006
  25. Sobal J, Rauschenbach B, Frongillo EA. Marital status changes and body weight changes: a US longitudinal analysis. Soc Sci Med 2003;56:1543-55. https://doi.org/10.1016/S0277-9536(02)00155-7
  26. Stubbs RJ, Harbron CG, Murgatroyd PR, Prentice AM. Covert manipulation of dietary fat and energy density: effect on substrate flux and food intake in men eating ad libitum. Am J Clin Nutr 1995;62:316-29. https://doi.org/10.1093/ajcn/62.2.316
  27. Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 2001;357:505-8. https://doi.org/10.1016/S0140-6736(00)04041-1
  28. Yuan YQ, Li F, Meng P, et al. Gender difference on the association between dietary patterns and obesity in Chinese middle-aged and elderly populations. Nutrients 2016;8:448.
  29. Rolls BJ, Engell D, Birch LL. Serving portion size influences 5-year-old but not 3-year-old children's food intakes. J Am Diet Assoc 2000;100:232-4. https://doi.org/10.1016/S0002-8223(00)00070-5
  30. Sung KC, Kim SH, Reaven GM. Relationship among alcohol, body weight, and cardiovascular risk factors in 27,030 Korean men. Diabetes Care 2007;30:2690-4. https://doi.org/10.2337/dc07-0315
  31. Yeomans MR. Alcohol, appetite and energy balance: is alcohol intake a risk factor for obesity? Physiol Behav 2010;100:82-9. https://doi.org/10.1016/j.physbeh.2010.01.012
  32. Rojdmark S, Calissendorff J, Brismar K. Alcohol ingestion decreases both diurnal and nocturnal secretion of leptin in healthy individuals. Clin Endocrinol (Oxf) 2001;55:639-47. https://doi.org/10.1046/j.1365-2265.2001.01401.x
  33. Sayon-Orea C, Martinez-Gonzalez MA, Bes-Rastrollo M. Alcohol consumption and body weight: a systematic review. Nutr Rev 2011;69:419-31. https://doi.org/10.1111/j.1753-4887.2011.00403.x
  34. Traversy G, Chaput JP. Alcohol consumption and obesity: an update. Curr Obes Rep 2015;4:122-30. https://doi.org/10.1007/s13679-014-0129-4
  35. Swinburn BA, Caterson I, Seidell JC, James WP. Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr 2004;7:123-46.
  36. Darmon N, Briend A, Drewnowski A. Energy-dense diets are associated with lower diet costs: a community study of French adults. Public Health Nutr 2004;7:21-7. https://doi.org/10.1079/PHN2003512
  37. Ball K, Crawford D. Socioeconomic status and weight change in adults: a review. Soc Sci Med 2005;60:1987-2010. https://doi.org/10.1016/j.socscimed.2004.08.056
  38. Fernald LC. Socio-economic status and body mass index in low-income Mexican adults. Soc Sci Med 2007;64:2030-42. https://doi.org/10.1016/j.socscimed.2007.02.002
  39. Gortmaker SL, Peterson K, Wiecha J, et al. Reducing obesity via a school-based interdisciplinary intervention among youth: Planet Health. Arch Pediatr Adolesc Med 1999;153:409-18. https://doi.org/10.1001/archpedi.153.4.409
  40. Campbell K, Crawford D. Family food environments as determinants of preschool-aged children's eating behaviours: implications for obesity prevention policy. A review. Aust J Nutr Diet 2001;58:19-26.
  41. Lewis MK, Hill AJ. Food advertising on British children's television: a content analysis and experimental study with nine-year olds. Int J Obes Relat Metab Disord 1998;22:206-14. https://doi.org/10.1038/sj.ijo.0800568
  42. Wharton S, Raiber L, Serodio KJ, Lee J, Christensen RA. Medications that cause weight gain and alternatives in Canada: a narrative review. Diabetes Metab Syndr Obes 2018;11:427-38. https://doi.org/10.2147/DMSO.S171365
  43. Berthon BS, Gibson PG, McElduff P, MacDonald-Wicks LK, Wood LG. Effects of short-term oral corticosteroid intake on dietary intake, body weight and body composition in adults with asthma - a randomized controlled trial. Clin Exp Allergy 2015;45:908-19. https://doi.org/10.1111/cea.12505
  44. Wung PK, Anderson T, Fontaine KR, et al. Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis. Arthritis Rheum 2008;59:746-53. https://doi.org/10.1002/art.23561
  45. Hjelmesaeth J, Hartmann A, Kofstad J, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997;64:979-83. https://doi.org/10.1097/00007890-199710150-00008
  46. McKenzie R, O'Fallon A, Dale J, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 1998;280:1061-6. https://doi.org/10.1001/jama.280.12.1061
  47. ElSayed NA, Aleppo G, Aroda VR, et al. Introduction and methodology: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl 1):S1-4. https://doi.org/10.2337/dc23-Sint
  48. Tsapas A, Karagiannis T, Kakotrichi P, et al. Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: a systematic review and network meta-analysis. Diabetes Obes Metab 2021;23:2116-24. https://doi.org/10.1111/dom.14451
  49. Sharma AM, Pischon T, Hardt S, Kunz I, Luft FC. Hypothesis: beta-adrenergic receptor blockers and weight gain: a systematic analysis. Hypertension 2001;37:250-4. https://doi.org/10.1161/01.HYP.37.2.250
  50. Cheskin LJ, Bartlett SJ, Zayas R, Twilley CH, Allison DB, Contoreggi C. Prescription medications: a modifiable contributor to obesity. South Med J 1999;92:898-904. https://doi.org/10.1097/00007611-199909000-00009
  51. Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 2010;71:1259-72. https://doi.org/10.4088/JCP.09r05346blu
  52. Jang HC. Recent progression in sarcopenia and sarcopenic obesity. J Korean Geriatr Soc 2011;15:1-7. https://doi.org/10.4235/jkgs.2011.15.1.1
  53. Kim BJ. Obesity and sex hormones. Korean J Obes 2010;19:113-8.
  54. Poehlman ET. Regulation of energy expenditure in aging humans. J Am Geriatr Soc 1993;41:552-9. https://doi.org/10.1111/j.1532-5415.1993.tb01895.x
  55. Brown LM, Clegg DJ. Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol 2010;122:65-73. https://doi.org/10.1016/j.jsbmb.2009.12.005
  56. Arner P, Andersson DP, Backdahl J, Dahlman I, Ryden M. Weight gain and impaired glucose metabolism in women are predicted by inefficient subcutaneous fat cell lipolysis. Cell Metab 2018;28:45-54.e3. https://doi.org/10.1016/j.cmet.2018.05.004
  57. Frankl J, Piaggi P, Foley JE, Krakoff J, Votruba SB. In vitro lipolysis is associated with whole-body lipid oxidation and weight gain in humans. Obesity (Silver Spring) 2017;25:207-14. https://doi.org/10.1002/oby.21670
  58. Lehr S, Hartwig S, Lamers D, et al. Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteomics 2012;11:M111.010504.
  59. Lee P, Linderman JD, Smith S, et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab 2014;19:302-9. https://doi.org/10.1016/j.cmet.2013.12.017
  60. Vinales KL, Begaye B, Bogardus C, Walter M, Krakoff J, Piaggi P. FGF21 is a hormonal mediator of the human "thrifty" metabolic phenotype. Diabetes 2019;68:318-23. https://doi.org/10.2337/db18-0696
  61. Coskun T, Bina HA, Schneider MA, et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 2008;149:6018-27. https://doi.org/10.1210/en.2008-0816
  62. Gaich G, Chien JY, Fu H, et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab 2013;18:333-40. https://doi.org/10.1016/j.cmet.2013.08.005
  63. Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Lands-berg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991;17:669-77. https://doi.org/10.1161/01.HYP.17.5.669
  64. Lee ZS, Critchley JA, Tomlinson B, et al. Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metabolism 2001;50:135-43. https://doi.org/10.1053/meta.2001.19502
  65. Gudmundsdottir H, Strand A, Kjeldsen S, Hoieggen A, Os I. Arterial noradrenaline predicts rise in body mass index in a 20-year follow-up of lean normotensive and hypertensive men. J Hypertens 2008;26:S347.
  66. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003;42:474-80. https://doi.org/10.1161/01.HYP.0000091371.53502.D3
  67. Flaa A, Sandvik L, Kjeldsen SE, Eide IK, Rostrup M. Does sympathoadrenal activity predict changes in body fat? An 18-y follow-up study. Am J Clin Nutr 2008;87:1596-601. https://doi.org/10.1093/ajcn/87.6.1596
  68. Macdonald I, Bennett T, Fellows I. Catecholamines and the control of metabolism in man. Clin Sci 1985;68:613-9. https://doi.org/10.1042/cs0680613
  69. Tataranni PA, Young JB, Bogardus C, Ravussin E. A low sympathoadrenal activity is associated with body weight gain and development of central adiposity in Pima Indian men. Obes Res 1997;5:341-7. https://doi.org/10.1002/j.1550-8528.1997.tb00562.x
  70. Reisin E, Weir MR, Falkner B, Hutchinson HG, Anzalone DA, Tuck ML. Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group. Hypertension 1997;30(1 Pt 1):140-5. https://doi.org/10.1161/01.HYP.30.1.140
  71. Cotter G, Weissgarten J, Metzkor E, et al. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther 1997;62:187-93. https://doi.org/10.1016/S0009-9236(97)90067-9
  72. Ivanov K, Mychka V, Prokhorova J, et al. The effectiveness of therapy perindopril arginine in treatment of patients with hypertension and diabetes type 2 in national program "PREMIA". J Hypertens 2011;29:e236.
  73. de Luis DA, Conde R, Gonzalez-Sagrado M, et al. Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients. Nutr Hosp 2010;25:275-9.
  74. Al-Thanoon ZA, Mahmood IH. Effects of losartan vs. enalapril on the markers of metabolic syndrome. Oman Med J 2012;27:27-30. https://doi.org/10.5001/omj.2012.05
  75. Chrysant SG, Chrysant C, Trus J, Hitchcock A. Antihypertensive effectiveness of amlodipine in combination with hydrochlorothiazide. Am J Hypertens 1989;2:537-41. https://doi.org/10.1093/ajh/2.7.537